Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months– – Combination ...

Thank you very much. Very much appreciate it. And I don't mind making this speech without a teleprompter because the teleprompter is not working. [Laughter] I feel very happy to be up here with you ...